| Autor: |
Isenberg, David A, Lin, Celia J F |
| Předmět: |
|
| Zdroj: |
Rheumatology; Apr2023, Vol. 62 Issue 4, p1359-1361, 3p |
| Abstrakt: |
The authors discusses the potential of atacicept as an effective treatment for systemic lupus erythematosus (SLE). They cite how atacicept impacts on B cell and plasma cell growth and differentiation but its use for the right disease indication is still being explored. In a phase III trial, the atacicept demonstrated its beneficial effect compared with placebo in patients with SLE while a safety analysis also showed that atacicept were not linked to increased infection rates. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
